Vimarsana
Biggest News Aggregation in the World

Page 40 - Structural Heart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Structural Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Structural Heart Today - Breaking & Trending Today

Tricuspid Valve Repair System Shows Promising Results at One-year Follow-up - Vimarsana News

Tricuspid Valve Repair System Shows Promising Results at One-year Follow-up

Study further validates transcatheter edge-to-edge strategy to treat tricuspid regurgitation.

New data on significant blood pressure reduction - Vimarsana News

New data on significant blood pressure reduction

Medtronic plc today announced long-term data from the first 80 patients in the SPYRAL HTN-ON MED trial, which were presented today at the American College

Novel transcatheter repair system for tricuspid regurgitation shows promising results at one year - Vimarsana News

Novel transcatheter repair system for tricuspid regurgitation shows promising results at one year

Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who received a novel investigational device intended to repair the defective valve experienced significant improvements in blood flow through the heart and in quality of life at one year, according to research presented at the American College of Cardiology's 71st Annual Scientific Session.

Meddux Appoints Margery Parsell Director of Business Development - Vimarsana News

Meddux Appoints Margery Parsell Director of Business Development

/PRNewswire/ -- Meddux, an engineering, design, development and manufacturing company serving OEMs, CEOs, Physicians, Universities, and Start-ups for the...

ACC.22: Medtronic renal denervation system demonstrates significant blood pressure reduction through three years - Vimarsana News

ACC.22: Medtronic renal denervation system demonstrates significant blood pressure reduction through three years

/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced long-term data from the first 80 patients in the SPYRAL...